Insulin Receptor Substrate 1 (IRS1) (Internal Region) Peptide

Details for Product No. ABIN1382272
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms irs1, irsu, IRS1, HIRS-1, G972R, IRS-1, IRS1IRM, irs-1, irs1-a
Protein Region
Internal Region
Origin
Human
Application
Blocking Peptide (BP)
Pubmed 3 references available
Quantity 0.05 mg
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Characteristics 16 amino acids near the center of human IRS-1.
Human
Alternative Name IRS-1
Application Notes IRS-1peptide is used for blocking the activity of IRS-1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications McGettrick, ONeill: "The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction." in: Molecular immunology, Vol. 41, Issue 6-7, pp. 577-82, 2004 (PubMed).

Zhang, Ghosh: "Negative regulation of toll-like receptor-mediated signaling by Tollip." in: The Journal of biological chemistry, Vol. 277, Issue 9, pp. 7059-65, 2002 (PubMed).

Giovannone, Scaldaferri, Federici et al.: "Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential." in: Diabetes/metabolism research and reviews, Vol. 16, Issue 6, pp. 434-41, 2001 (PubMed).

Validation Images
Catalog No. ABIN1382272
93.50 $
Plus shipping costs $45.00
Quantity
Price
0.05 mg
93.50 $

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
back to top